MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2017 International Congress

    Probiotic correction of intestinal dysbiosis in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To reveal the effect of probiotic on the content and condition of intestinal microbiota in Parkinson's disease (PD). Background: Constipation is an important non-motor…
  • 2017 International Congress

    Detection of Early Changes in Microbiota Composition in Prodromal Parkinson’s Disease

    J. Boertien, T. Van Laar (Groningen, Netherlands)

    Objective: To identify predictive markers of Parkinson’s disease (PD) in the gut microbiota composition of subjects at risk for developing PD due to a positive…
  • 2016 International Congress

    The correlation between dietary fiber, fluid intake and constipation in patients with Parkinson’s disease

    N. Kawashima, A. Tabata, A. Kumon, K. Miyashita, A. Sato, H. Onuma, S. Nakamura, E. Horiuchi, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the correlation between high dietary fiber, fluid intake and constipation in Parkinson's disease (PD) patients. Background: Constipation is one of the complications…
  • 2016 International Congress

    Osteopathic manipulative treatment in Parkinson’s disease: Preliminary results of a double blind sham-controlled cross-over study

    S. Varanese, L. Cicchitti, G. Travaglini, V. Carafa, N. Modugno, S. Spinelli, F. Marsicano, M. Mistichelli, F. Marsicano, F. Giorgini, M. Verzella (Pozzilli, Italy)

    Objective: The primary objective of this study is to quantitatively evaluate the effect of osteopathic manipulative treatment (OMT) in Parkinson's disease. Background: Patients with Parkinson's…
  • 2016 International Congress

    The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

    T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

    Objective: To assess the prevalence of constipation and irritable bowel syndrome (IBS) in Parkinson's disease (PD) patients using Rome III in our cohort. Background: Gastrointestinal…
  • 2016 International Congress

    Survey of prodromal symptoms of Parkinson’s disease in Japan

    M. Yogo, M. Morita, M. Suzuki (Katsushika-ku, Japan)

    Objective: To reveal prodromal symptoms at a public seminar for PD via questionnaires. Background: How to select subjects with PD for disease modify therapy in…
  • 2016 International Congress

    A case series of sigmoid volvulus in Parkinson’s disease

    K. Khalid, A. McColl, M. Gosney, A.K. Chatterjee (Reading, United Kingdom)

    Objective: To study the outcomes of patients with Parkinson's disease (PD) who were admitted with a diagnosis of sigmoid volvulus. Background: Constipation is a common…
  • 2016 International Congress

    Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives

    P. Themann (Halsbrücke, Germany)

    Objective: The purpose of this survey was to determine the awareness and perception of gastrointestinal (GI) symptoms in patients and caregiving relatives (for simplicity hereunder…
  • 2016 International Congress

    Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

    V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)

    Objective: To evaluate patient's awareness of reversible causes of worsening of Parkinson's disease (PD)1, their impact on symptoms and the role of abdominal x-ray (PFA)…
  • 2016 International Congress

    α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

    H. Sumikura, J. Fujigasaki, Y. Nakano, A. Uchino, Y. Saito, H. Mochizuki, S. Murayama (Tokyo, Japan)

    Objective: To examine whether the degree of α-synuclein (α-Syn) in the peripheral organs of patients with Lewy body disease (LBD: Parkinson's disease, dementia with Lewy…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley